Review

mouse monoclonal anti rab8a (Novus Biologicals)

Novus Biologicals is a verified supplier

Novus Biologicals manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Novus Biologicals mouse monoclonal anti rab8a
Mouse Monoclonal Anti Rab8a, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+monoclonal+anti+rab8a/RAB8A+Antibody+(3G1)/pmc05702057-585-53-60
Average 90 stars, based on 9 article reviews

mouse monoclonal anti rab8a - by Bioz Stars, 2026-09

90/100 stars

Images

other:

Article Title: Integrin α8 and Pcdh15 act as a complex to regulate cilia biogenesis in sensory cells
Article Snippet: Other antibodies used in this study were: mouse monoclonal anti-actin, clone C4 (cat. #MAB1501, Millipore), mouse monoclonal anti-pan-centrin, clone 20H5 (cat. #04-1624, Millipore), mouse monoclonal anti-acetylated tubulin 6-11B-1 (cat. #T6793, Sigma-Aldrich), mouse monoclonal anti-γ-tubulin clone GTU-88 (cat. #T6557, Sigma-Aldrich), chicken anti-GFP (cat. #NB100-1614, Novus Biologicals), mouse polyclonal anti-Rabin8 (RAB3IP) (cat. #H00117177-B01P, Novus Biologicals), mouse monoclonal anti-Rab8a clone 3G1 (cat. #H00004218-M02, Novus Biologicals), mouse monoclonal anti-6x-His epitope tag HIS.H8 (cat. #MA1-21315, Thermo Scientific), rabbit anti-Rab11a/b (cat. #GTX128847, Gene Tex), mouse monoclonal anti-Rhoa 26C4 (cat. #sc-418, Santa Cruz Biotechnology), mouse monoclonal anti-V5 epitope (cat. #R960-25, Thermo Scientific), rabbit anti-IFT54 (cat. #ARP55316_P050, Aviva Systems Biology) and mouse anti-Cc2d2a ( Bachmann-Gagescu et al., 2011 ).

Article Title: Ahi1, whose human ortholog is mutated in Joubert syndrome, is required for Rab8a localization, ciliogenesis and vesicle trafficking
Article Snippet: The following antibodies were used for immuno-labelling: rabbit polyclonal anti-Ahi1 (1:1000; ( 34 )), mouse monoclonal anti-γ-tubulin (1:1000; Sigma), mouse monoclonal anti-acetylated α-tubulin (1:1000; Sigma), mouse monoclonal anti-GM130 (1:1000; BD Biosciences, San Jose, CA, USA), rabbit polyclonal anti-Golph4 (1:500; Abcam, Cambridge, MA, USA), mouse monoclonal anti-Rab8a (1:50; Novus Biologicals, Littleton, CO, USA), rabbit polyclonal anti-ninein (1:100; Millipore, Billerica, MA, USA), goat polyclonal anti-Odf2 (1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse monoclonal anti-HA (1:1000; Cell Signalling Technology, Danvers, MA, USA), and rabbit polyclonal anti-HA (1:100; Clontech, Mountain View, CA, USA).

Article Title: Integrin α8 and Pcdh15 act as a complex to regulate cilia biogenesis in sensory cells.
Article Snippet: Other antibodies used in this study were: mouse monoclonal anti-actin, clone C4 (cat. #MAB1501, Millipore), mouse monoclonal anti-pan-centrin, clone 20H5 (cat. #04-1624, Millipore), mouse monoclonal anti-acetylated tubulin 6-11B-1 (cat. #T6793, Sigma-Aldrich), mouse monoclonal anti-γtubulin clone GTU-88 (cat. #T6557, Sigma-Aldrich), chicken anti-GFP (cat. #NB100-1614, Novus Biologicals), mouse polyclonal anti-Rabin8 (RAB3IP) (cat. #H00117177-B01P, Novus Biologicals), mouse monoclonal anti-Rab8a clone 3G1 (cat. #H00004218-M02, Novus Biologicals), mouse monoclonal anti-6x-His epitope tag HIS.H8 (cat. #MA1-21315, Thermo Scientific), rabbit anti-Rab11a/b (cat. #GTX128847, Gene Tex), mouse monoclonal anti-Rhoa 26C4 (cat. #sc-418, Santa Cruz Biotechnology), mouse monoclonal anti-V5 epitope (cat. #R960-25, Thermo Scientific), rabbit anti-IFT54 (cat. #ARP55316_P050, Aviva Systems Biology) and mouse anti-Cc2d2a (Bachmann-Gagescu et al., 2011).

Article Title: Loss-of-function of the ciliopathy protein Cc2d2a disorganizes the vesicle fusion machinery at the periciliary membrane and indirectly affects Rab8-trafficking in zebrafish photoreceptors
Article Snippet: Primary antibodies were rabbit anti-Syntaxin3 (1:400, Alomone labs, ANR-005), rabbit anti-SNAP25 (1:1000, StressGen Biotechnologies, VAP-SV002), mouse monoclonal anti-Rab8a (1:100, Novus Biologicals, clone 3G1), rabbit anti-Cacna1fa (1:5000, a gift from Michael Taylor, University of Wisconsin [ ]), rabbit anti-blue opsin (1:250, gift from David Hyde) and rabbit anti green opsin (1:400, gift from David Hyde, University of Notre Dame).

Image Search Results

Active RAB8A and Rabin8 rescue the LRRK2-mediated deficit in EGF binding and degradation. A , HeLa cells were transfected with either empty pCMV vector ( ctrl ) or the indicated RAB8A constructs followed by quantification of the amount of surface-bound fluorescent EGF. n = 4 independent experiments. *, p < 0.05. B , cells were transfected as indicated followed by quantification of internalized Alexa555-EGF in transfected cells after 10 ( left ) and 30 min ( right ) of internalization. Values are normalized to the amount of Alexa555-EGF binding at t = 0. n = 4 independent experiments. *, p < 0.05. C , cells were cotransfected with G2019S LRRK2 and the indicated RAB8A constructs, and surface-bound fluorescent EGF was quantified. n = 8 independent experiments. *, p < 0.05. D , cells were cotransfected with G2019S LRRK2 and the indicated RAB8A constructs followed by quantification of internalized Alexa555-EGF after 10 ( left ) and 30 min ( right ) of internalization. n = 8 independent experiments. ****, p < 0.001. E , cells were transfected with either empty pCMV vector ( ctrl ) or with Rabin8, and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. F , cells were transfected as indicated followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. G , cells were transfected with either empty pCMV vector ( ctrl ) or cotransfected with G2019S pathogenic LRRK2 and either pCMV vector or Rabin8 as indicated, and surface-bound fluorescent EGF was quantified. n = 3 experiments. *, p < 0.05. H , cells were transfected as indicated followed by quantification of internalized fluorescent EGF as described above. n = 3 independent experiments. ***, p < 0.005. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Active RAB8A and Rabin8 rescue the LRRK2-mediated deficit in EGF binding and degradation. A , HeLa cells were transfected with either empty pCMV vector ( ctrl ) or the indicated RAB8A constructs followed by quantification of the amount of surface-bound fluorescent EGF. n = 4 independent experiments. *, p < 0.05. B , cells were transfected as indicated followed by quantification of internalized Alexa555-EGF in transfected cells after 10 ( left ) and 30 min ( right ) of internalization. Values are normalized to the amount of Alexa555-EGF binding at t = 0. n = 4 independent experiments. *, p < 0.05. C , cells were cotransfected with G2019S LRRK2 and the indicated RAB8A constructs, and surface-bound fluorescent EGF was quantified. n = 8 independent experiments. *, p < 0.05. D , cells were cotransfected with G2019S LRRK2 and the indicated RAB8A constructs followed by quantification of internalized Alexa555-EGF after 10 ( left ) and 30 min ( right ) of internalization. n = 8 independent experiments. ****, p < 0.001. E , cells were transfected with either empty pCMV vector ( ctrl ) or with Rabin8, and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. F , cells were transfected as indicated followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. G , cells were transfected with either empty pCMV vector ( ctrl ) or cotransfected with G2019S pathogenic LRRK2 and either pCMV vector or Rabin8 as indicated, and surface-bound fluorescent EGF was quantified. n = 3 experiments. *, p < 0.05. H , cells were transfected as indicated followed by quantification of internalized fluorescent EGF as described above. n = 3 independent experiments. ***, p < 0.005. All error bars represent S.E.M.

Article Snippet: Antibodies used for immunoblotting included a rabbit polyclonal anti-GFP (1:2000; Abcam, ab6556), a mouse monoclonal anti-GAPDH (1:2000; Abcam, ab9484), a mouse monoclonal anti-LRRK2 (1:1000; NeuroMab, 75-253), a mouse monoclonal anti-RAB8A antibody (1:1000; BD Biosciences, 610844), a mouse monoclonal anti-tubulin antibody (clone DM1A; 1:10,000; Sigma), a sheep polyclonal anti-RAB8A antibody (1:500; S969D, MRC-PPU Reagents), a rabbit polyclonal anti-RAB7 antibody (1:1000; Sigma, R4779), a mouse monoclonal anti-RAB11 antibody (1:1000; BD Biosciences, 610656), and a knockout-validated rabbit monoclonal anti-RAB4 antibody (1:1000; Abcam, ab109009).

Techniques: Binding Assay, Transfection, Plasmid Preparation, Construct

Phosphodeficient RAB8A, but not WT or phosphomimetic RAB8A variants, revert the LRRK2-mediated effects on EGFR trafficking. A , HeLa cells were transfected with either empty pCMV vector ( ctrl ) or the indicated RAB8A constructs, and surface-bound fluorescent EGF was quantified. n = 4 independent experiments. *, p < 0.05. B , cells were transfected with the indicated constructs followed by quantification of internalized fluorescent EGF. n = 4 independent experiments. *, p < 0.05. C , cells were cotransfected with G2019S LRRK2 and the indicated RAB8A constructs, and surface-bound fluorescent EGF was quantified. n = 8 independent experiments. *, p < 0.05. D , cells were transfected with the indicated constructs, and internalized fluorescent EGF was quantified at 10 ( left ) and 30 min ( right ). n = 8 independent experiments. *, p < 0.05; ***, p < 0.005; ****, p < 0.001. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Phosphodeficient RAB8A, but not WT or phosphomimetic RAB8A variants, revert the LRRK2-mediated effects on EGFR trafficking. A , HeLa cells were transfected with either empty pCMV vector ( ctrl ) or the indicated RAB8A constructs, and surface-bound fluorescent EGF was quantified. n = 4 independent experiments. *, p < 0.05. B , cells were transfected with the indicated constructs followed by quantification of internalized fluorescent EGF. n = 4 independent experiments. *, p < 0.05. C , cells were cotransfected with G2019S LRRK2 and the indicated RAB8A constructs, and surface-bound fluorescent EGF was quantified. n = 8 independent experiments. *, p < 0.05. D , cells were transfected with the indicated constructs, and internalized fluorescent EGF was quantified at 10 ( left ) and 30 min ( right ). n = 8 independent experiments. *, p < 0.05; ***, p < 0.005; ****, p < 0.001. All error bars represent S.E.M.

Techniques: Transfection, Plasmid Preparation, Construct

Knockdown of RAB8A mimics the endolysosomal trafficking deficits mediated by G2019S LRRK2. A , HeLa cells were either nontransfected (−) or transfected with ctrl-siRNA or RAB8A-siRNA, and cell extracts (30 μg) were analyzed by Western blotting for RAB8A protein levels and tubulin as a loading control. B , quantification of the type of experiments depicted in A . RAB8A levels in the presence of RAB8A-siRNA were normalized to levels in the presence of ctrl-siRNA. n = 3 independent experiments. *, p < 0.05. C , cells were either left untreated (−) or transfected with ctrl-siRNA or RAB8A-siRNA, and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. D , cells were either left untreated (−) or transfected with ctrl-siRNA or RAB8A-siRNA followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. **, p < 0.01; ****, p < 0.001. E , cells were either left untreated or cotransfected with ctrl-siRNA or RAB8A-siRNA in the absence or presence of GFP-tagged active RAB7A (RAB7A-Q67L), and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. F , cells were either left untreated or cotransfected with ctrl-siRNA or RAB8A-siRNA in the absence or presence of RAB7A-Q67L, and internalized fluorescent EGF was quantified at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. *, p < 0.05; **, p < 0.01. G , cells were either treated with ctrl-siRNA or RAB8A-siRNA as indicated, and the RAB7-binding domain of RILP coupled to GST was used to pull down the GTP-bound form of RAB7 from cell lysates (300 μg). Input (10%) was run alongside pulldowns to demonstrate equal levels of total RAB7 protein in ctrl-siRNA– or RAB8A-siRNA–treated cells, and the levels of RAB8A and tubulin were analyzed on a separate gel. H , experiments of the type depicted in G were quantified, and the amount of RAB7 isolated by GST-RILP was expressed relative to input. n = 3 independent experiments. ***, p < 0.005. I , cells were either treated with ctrl-siRNA or RAB8A-siRNA as indicated, and a conformation-specific antibody was used to immunoprecipitate active RAB7 from cell lysates (2 mg). As a positive control, ctrl-siRNA–treated cell extracts were incubated with 100 μ m GTPγS to activate RAB7A before immunoprecipitation. Input (1%) was run alongside pulldowns to demonstrate equal levels of total RAB7 protein in ctrl-siRNA– or RAB8A-siRNA–treated cells, and the levels of RAB8A and tubulin were analyzed on a separate gel. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Knockdown of RAB8A mimics the endolysosomal trafficking deficits mediated by G2019S LRRK2. A , HeLa cells were either nontransfected (−) or transfected with ctrl-siRNA or RAB8A-siRNA, and cell extracts (30 μg) were analyzed by Western blotting for RAB8A protein levels and tubulin as a loading control. B , quantification of the type of experiments depicted in A . RAB8A levels in the presence of RAB8A-siRNA were normalized to levels in the presence of ctrl-siRNA. n = 3 independent experiments. *, p < 0.05. C , cells were either left untreated (−) or transfected with ctrl-siRNA or RAB8A-siRNA, and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. D , cells were either left untreated (−) or transfected with ctrl-siRNA or RAB8A-siRNA followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. **, p < 0.01; ****, p < 0.001. E , cells were either left untreated or cotransfected with ctrl-siRNA or RAB8A-siRNA in the absence or presence of GFP-tagged active RAB7A (RAB7A-Q67L), and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. F , cells were either left untreated or cotransfected with ctrl-siRNA or RAB8A-siRNA in the absence or presence of RAB7A-Q67L, and internalized fluorescent EGF was quantified at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. *, p < 0.05; **, p < 0.01. G , cells were either treated with ctrl-siRNA or RAB8A-siRNA as indicated, and the RAB7-binding domain of RILP coupled to GST was used to pull down the GTP-bound form of RAB7 from cell lysates (300 μg). Input (10%) was run alongside pulldowns to demonstrate equal levels of total RAB7 protein in ctrl-siRNA– or RAB8A-siRNA–treated cells, and the levels of RAB8A and tubulin were analyzed on a separate gel. H , experiments of the type depicted in G were quantified, and the amount of RAB7 isolated by GST-RILP was expressed relative to input. n = 3 independent experiments. ***, p < 0.005. I , cells were either treated with ctrl-siRNA or RAB8A-siRNA as indicated, and a conformation-specific antibody was used to immunoprecipitate active RAB7 from cell lysates (2 mg). As a positive control, ctrl-siRNA–treated cell extracts were incubated with 100 μ m GTPγS to activate RAB7A before immunoprecipitation. Input (1%) was run alongside pulldowns to demonstrate equal levels of total RAB7 protein in ctrl-siRNA– or RAB8A-siRNA–treated cells, and the levels of RAB8A and tubulin were analyzed on a separate gel. All error bars represent S.E.M.

Techniques: Transfection, Western Blot, Binding Assay, Isolation, Positive Control, Incubation, Immunoprecipitation

Pathogenic LRRK2 or knockdown of RAB8A causes accumulation of EGF in a RAB4-positive endocytic compartment. A , HeLa cells were transfected with either empty pCMV vector or pathogenic LRRK2 or cotransfected with GFP-tagged RAB4, and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. B , cells were transfected as indicated followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. *, p < 0.05; **, p < 0.01. C , example of HeLa cells cotransfected with GFP-RAB4 and either empty pCMV vector or pathogenic LRRK2. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. Scale bar , 10 μm. D , quantification of colocalization of Alexa647-EGF with GFP-RAB4 (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 6 independent experiments. ***, p < 0.005. E , example of HeLa cells cotransfected with GFP-RAB4 and either ctrl-siRNA or RAB8A-siRNA. Live pictures were taken as described above. Arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. Scale bar , 10 μm. F , quantification of colocalization of Alexa647-EGF with GFP-RAB4 (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Pathogenic LRRK2 or knockdown of RAB8A causes accumulation of EGF in a RAB4-positive endocytic compartment. A , HeLa cells were transfected with either empty pCMV vector or pathogenic LRRK2 or cotransfected with GFP-tagged RAB4, and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. B , cells were transfected as indicated followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. *, p < 0.05; **, p < 0.01. C , example of HeLa cells cotransfected with GFP-RAB4 and either empty pCMV vector or pathogenic LRRK2. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. Scale bar , 10 μm. D , quantification of colocalization of Alexa647-EGF with GFP-RAB4 (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 6 independent experiments. ***, p < 0.005. E , example of HeLa cells cotransfected with GFP-RAB4 and either ctrl-siRNA or RAB8A-siRNA. Live pictures were taken as described above. Arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. Scale bar , 10 μm. F , quantification of colocalization of Alexa647-EGF with GFP-RAB4 (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01. All error bars represent S.E.M.

Techniques: Transfection, Plasmid Preparation

Accumulation of EGF in a RAB4-positive endocytic compartment and deficits in EGFR recycling due to knockdown of RAB8A are rescued by active RAB7A expression. A , example of HeLa cells cotransfected with GFP-RAB4 and either ctrl-siRNA or RAB8A-siRNA with or without RAB7A-Q67L expression as indicated. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. An independent picture (543 HeNe laser line) was acquired to confirm coexpression of the distinct mRFP-tagged RAB7A constructs in all cases. Scale bar , 10 μm. B , quantification of colocalization of Alexa647-EGF with GFP-RAB4 and either ctrl-siRNA or RAB8A-siRNA in the presence or absence of distinct RAB7A constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01; ***, p < 0.005. C , HeLa cells were treated with ctrl-siRNA or RAB8A-siRNA as indicated and transfected with the indicated RAB7A constructs, and cell extracts (30 μg) were analyzed by Western blotting for RAB8A protein levels, mRFP-RAB7A protein levels (anti-RAB7 antibody), and GAPDH as a loading control. D , HeLa cells were treated with either ctrl-siRNA or RAB8A-siRNA as indicated with or without cotransfection with the indicated RAB7A constructs. EGFR recycling assays were performed as described under “Materials and methods,” revealing a deficit in EGFR surface levels and EGFR recycling upon RAB8A-siRNA, which was rescued upon expression of active RAB7A. n = 3 independent experiments. *, p < 0.05; ***, p < 0.005; ****, p < 0.001. A.U. , arbitrary units. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Accumulation of EGF in a RAB4-positive endocytic compartment and deficits in EGFR recycling due to knockdown of RAB8A are rescued by active RAB7A expression. A , example of HeLa cells cotransfected with GFP-RAB4 and either ctrl-siRNA or RAB8A-siRNA with or without RAB7A-Q67L expression as indicated. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. An independent picture (543 HeNe laser line) was acquired to confirm coexpression of the distinct mRFP-tagged RAB7A constructs in all cases. Scale bar , 10 μm. B , quantification of colocalization of Alexa647-EGF with GFP-RAB4 and either ctrl-siRNA or RAB8A-siRNA in the presence or absence of distinct RAB7A constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01; ***, p < 0.005. C , HeLa cells were treated with ctrl-siRNA or RAB8A-siRNA as indicated and transfected with the indicated RAB7A constructs, and cell extracts (30 μg) were analyzed by Western blotting for RAB8A protein levels, mRFP-RAB7A protein levels (anti-RAB7 antibody), and GAPDH as a loading control. D , HeLa cells were treated with either ctrl-siRNA or RAB8A-siRNA as indicated with or without cotransfection with the indicated RAB7A constructs. EGFR recycling assays were performed as described under “Materials and methods,” revealing a deficit in EGFR surface levels and EGFR recycling upon RAB8A-siRNA, which was rescued upon expression of active RAB7A. n = 3 independent experiments. *, p < 0.05; ***, p < 0.005; ****, p < 0.001. A.U. , arbitrary units. All error bars represent S.E.M.

Techniques: Expressing, Construct, Transfection, Western Blot, Cotransfection

Expression of dominant-negative RAB7A causes defects in EGFR trafficking, accumulation of EGF in a RAB4-positive endocytic compartment, and deficits in EGFR recycling, which are reversed upon active RAB8A expression. A , HeLa cells were transfected with either empty pCMV vector ( ctrl ) or with dominant-negative RAB7A (RAB7A-T22N) in the presence or absence of active RAB8A (RAB8A-Q67L), and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. B , cells were transfected with the indicated constructs followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. *, p < 0.05; **, p < 0.01. C , example of HeLa cells cotransfected with GFP-RAB4 and either mRFP-RAB7A-T22N or mRFP-RAB7A-T22N and FLAG-tagged RAB8A-Q67L as indicated. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. An independent picture (543 HeNe laser line) was acquired to confirm coexpression of the mRFP-tagged RAB7A constructs in all cases. Scale bar , 10 μm. D , quantification of colocalization of Alexa647-EGF with GFP-RAB4 in the presence or absence of the distinct RAB7A constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01. E , quantification of colocalization of Alexa647-EGF with GFP-RAB4 in the presence or absence of RAB7A-T22N and RAB8A-Q67L constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. *, p < 0.05. F , HeLa cells were transfected with the indicated constructs, and cell extracts (30 μg) were analyzed by Western blotting for mRFP-tagged RAB7A-T22N, FLAG-tagged RAB8A-Q67L, and GAPDH as a loading control. G , HeLa cells were transfected with either empty pCMV vector or dominant-negative RAB7A-T22N in the absence or presence of RAB8A-Q67L, and EGFR surface levels and EGFR recycling were determined at the indicated time points. n = 3 independent experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.005. A.U. , arbitrary units. All error bars represent S.E.M.

Journal: The Journal of Biological Chemistry

Article Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A

doi: 10.1074/jbc.RA118.005008

Figure Lengend Snippet: Expression of dominant-negative RAB7A causes defects in EGFR trafficking, accumulation of EGF in a RAB4-positive endocytic compartment, and deficits in EGFR recycling, which are reversed upon active RAB8A expression. A , HeLa cells were transfected with either empty pCMV vector ( ctrl ) or with dominant-negative RAB7A (RAB7A-T22N) in the presence or absence of active RAB8A (RAB8A-Q67L), and surface-bound fluorescent EGF was quantified. n = 3 independent experiments. *, p < 0.05. B , cells were transfected with the indicated constructs followed by quantification of internalized fluorescent EGF at 10 ( left ) and 30 min ( right ). n = 3 independent experiments. *, p < 0.05; **, p < 0.01. C , example of HeLa cells cotransfected with GFP-RAB4 and either mRFP-RAB7A-T22N or mRFP-RAB7A-T22N and FLAG-tagged RAB8A-Q67L as indicated. Live pictures were taken 20 min upon fluorescent EGF internalization, and arrows point to GFP-RAB4–positive vesicles containing Alexa647-EGF. An independent picture (543 HeNe laser line) was acquired to confirm coexpression of the mRFP-tagged RAB7A constructs in all cases. Scale bar , 10 μm. D , quantification of colocalization of Alexa647-EGF with GFP-RAB4 in the presence or absence of the distinct RAB7A constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. **, p < 0.01. E , quantification of colocalization of Alexa647-EGF with GFP-RAB4 in the presence or absence of RAB7A-T22N and RAB8A-Q67L constructs as indicated (Manders' coefficient 1 × 100) from 15–20 cells per experiment. n = 3 independent experiments. *, p < 0.05. F , HeLa cells were transfected with the indicated constructs, and cell extracts (30 μg) were analyzed by Western blotting for mRFP-tagged RAB7A-T22N, FLAG-tagged RAB8A-Q67L, and GAPDH as a loading control. G , HeLa cells were transfected with either empty pCMV vector or dominant-negative RAB7A-T22N in the absence or presence of RAB8A-Q67L, and EGFR surface levels and EGFR recycling were determined at the indicated time points. n = 3 independent experiments. *, p < 0.05; **, p < 0.01; ***, p < 0.005. A.U. , arbitrary units. All error bars represent S.E.M.

Techniques: Expressing, Dominant Negative Mutation, Transfection, Plasmid Preparation, Construct, Western Blot

Review

mouse monoclonal anti rab8a (Novus Biologicals)

Structured Review

Images

Related Articles

other:

Similar Products

Image Search Results